![Karen Foster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Foster
Keine laufenden Positionen mehr
Vermögen: 3 Mio $ am 31.07.2026
Profil
Karen Foster worked at ViaCord LLC from 2003 to 2016 as Vice President-Laboratory Operations.
From 2024 to 2026, worked at BioLife Solutions, Inc. as Chief Operations & Quality Officer.
Attended Michigan Technological University for undergraduate studies.
Completed graduate and MBAistration degrees at the University of Wisconsin-Milwaukee.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOLIFE SOLUTIONS, INC. 0,23 % | 23.03.2026 | 108.758 ( 0,23 % ) | 3 Mio $ | 31.07.2026 |
Ehemalige bekannte Positionen von Karen Foster
| Unternehmen | Position | Ende |
|---|---|---|
| BIOLIFE SOLUTIONS, INC. | Geschäftsführer | 31.03.2026 |
ViaCord LLC
 ViaCord LLC Aerospace & DefenseElectronic Technology Founded in 1993, ViaCord LLC specializes in cord blood and tissue banking, offering families the opportunity to preserve stem cells from their newborn’s umbilical cord for current and potential future medical uses. The company is based in Waltham, MA. The company provides services such as cord blood banking, cord tissue banking using a proprietary process to extract and store multiple stem cell types, and advanced genetic testing options including whole genome sequencing and various genetic insight panels for newborns and adults. Cord blood contains hematopoietic stem cells used in treating nearly 80 conditions, primarily inherited genetic diseases, and has been utilized in transplants for over three decades. Cord tissue stem cells, particularly mesenchymal stem cells, are under ongoing clinical research for conditions like cerebral palsy, autism, and multiple sclerosis. ViaCord offers educational resources, personalized guidance, a free information kit, and the Sibling Connection Program, which provides free cord blood collection, processing, and lifetime storage for newborn siblings of children diagnosed with treatable conditions requiring a sibling’s cord blood transplant. The company is accredited by regulatory bodies including the FDA and AABB and is backed by its parent company, Revvity. | Corporate Officer/Principal | 01.01.2016 |
Ausbildung von Karen Foster
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
22
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
BioLife Solutions, Inc.
 BioLife Solutions, Inc. Medical SpecialtiesHealth Technology Designs, manufactures, and markets proprietary and generic bio preservation media products for cells, tissues and organs | Health Technology |
Michigan Technological University
 Michigan Technological University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin-Milwaukee
 University of Wisconsin-Milwaukee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ViaCord LLC
ViaCord LLC Aerospace & DefenseElectronic Technology Founded in 1993, ViaCord LLC specializes in cord blood and tissue banking, offering families the opportunity to preserve stem cells from their newborn’s umbilical cord for current and potential future medical uses. The company is based in Waltham, MA. The company provides services such as cord blood banking, cord tissue banking using a proprietary process to extract and store multiple stem cell types, and advanced genetic testing options including whole genome sequencing and various genetic insight panels for newborns and adults. Cord blood contains hematopoietic stem cells used in treating nearly 80 conditions, primarily inherited genetic diseases, and has been utilized in transplants for over three decades. Cord tissue stem cells, particularly mesenchymal stem cells, are under ongoing clinical research for conditions like cerebral palsy, autism, and multiple sclerosis. ViaCord offers educational resources, personalized guidance, a free information kit, and the Sibling Connection Program, which provides free cord blood collection, processing, and lifetime storage for newborn siblings of children diagnosed with treatable conditions requiring a sibling’s cord blood transplant. The company is accredited by regulatory bodies including the FDA and AABB and is backed by its parent company, Revvity. | Electronic Technology |
